1. Home
  2. BTZ vs FTRE Comparison

BTZ vs FTRE Comparison

Compare BTZ & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BTZ
  • FTRE
  • Stock Information
  • Founded
  • BTZ 2006
  • FTRE 1996
  • Country
  • BTZ United States
  • FTRE United States
  • Employees
  • BTZ N/A
  • FTRE N/A
  • Industry
  • BTZ Finance Companies
  • FTRE Medical Specialities
  • Sector
  • BTZ Finance
  • FTRE Health Care
  • Exchange
  • BTZ Nasdaq
  • FTRE Nasdaq
  • Market Cap
  • BTZ 1.0B
  • FTRE 864.4M
  • IPO Year
  • BTZ N/A
  • FTRE N/A
  • Fundamental
  • Price
  • BTZ $11.04
  • FTRE $9.58
  • Analyst Decision
  • BTZ
  • FTRE Hold
  • Analyst Count
  • BTZ 0
  • FTRE 9
  • Target Price
  • BTZ N/A
  • FTRE $12.81
  • AVG Volume (30 Days)
  • BTZ 279.4K
  • FTRE 1.4M
  • Earning Date
  • BTZ 01-01-0001
  • FTRE 11-07-2025
  • Dividend Yield
  • BTZ 9.40%
  • FTRE N/A
  • EPS Growth
  • BTZ N/A
  • FTRE N/A
  • EPS
  • BTZ 1.41
  • FTRE N/A
  • Revenue
  • BTZ N/A
  • FTRE $2,733,500,000.00
  • Revenue This Year
  • BTZ N/A
  • FTRE N/A
  • Revenue Next Year
  • BTZ N/A
  • FTRE N/A
  • P/E Ratio
  • BTZ $7.57
  • FTRE N/A
  • Revenue Growth
  • BTZ N/A
  • FTRE N/A
  • 52 Week Low
  • BTZ $9.10
  • FTRE $3.97
  • 52 Week High
  • BTZ $11.13
  • FTRE $25.28
  • Technical
  • Relative Strength Index (RSI)
  • BTZ 52.71
  • FTRE 51.84
  • Support Level
  • BTZ $10.95
  • FTRE $9.21
  • Resistance Level
  • BTZ $11.14
  • FTRE $10.86
  • Average True Range (ATR)
  • BTZ 0.09
  • FTRE 0.62
  • MACD
  • BTZ 0.00
  • FTRE -0.06
  • Stochastic Oscillator
  • BTZ 57.89
  • FTRE 49.51

About BTZ BlackRock Credit Allocation Income Trust

Blackrock Credit Allocation Income Trust is a diversified, closed-end Trust engaged in providing investment advisory and risk management solutions. Its investment objective is to seek current income, current gains, and capital appreciation. The company invests under normal market conditions, at least 80% of its assets in credit-related securities, including, but not limited to, investment-grade corporate bonds, high-yields, bank loans, preferred securities or convertible bonds, or derivatives with economic characteristics similar to these credit-related securities.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: